BioStream Technologies was founded with the core mission of developing scientifically-backed electronic interventions to aid children with autism spectrum disorder (ASD). The company’s primary product is a video game therapy designed to enhance social skills and emotion recognition in children with ASD. By integrating applied behavior analysis with gaze-contingent eye tracking, BioStream aims to create engaging and effective therapeutic experiences. Their market focus is on healthcare providers, educational institutions, and families seeking innovative treatments for autism.

Notable affiliated individuals include researchers Sosnowski, Stough, and Weiss, who contributed to a pilot study published in the Journal of Autism and Developmental Disorders. This study highlighted the efficacy of BioStream’s digital therapeutic approach. Key achievements include the successful completion of this pilot study, which demonstrated improvements in emotion recognition among participants. BioStream Technologies has made a significant impact by combining cutting-edge technology with behavioral science, offering new hope and tools for children with autism and their caregivers.